TETRALOGIC PHARMACEUTICALS CORP Net Cash Provided by (Used in) Continuing Operations
TETRALOGIC PHARMACEUTICALS CORP reported Net Cash Provided by (Used in) Continuing Operations of $3.90 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2015-05-14
- TETRALOGIC PHARMACEUTICALS CORP net cash provided by (used in) continuing operations for the quarter ending 2015-03-31 was $3.90M.
- TETRALOGIC PHARMACEUTICALS CORP net cash provided by (used in) continuing operations for the quarter ending 2014-12-31 was -$3.95M, a 107.49% decline year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP net cash provided by (used in) continuing operations for the quarter ending 2014-09-30 was -$23.22M.
- TETRALOGIC PHARMACEUTICALS CORP net cash provided by (used in) continuing operations for the quarter ending 2014-06-30 was $19.53M, a 271.48% increase year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP net cash provided by (used in) continuing operations for fiscal 2014 was -$42.06M, a 183.09% decline from fiscal 2013.
- TETRALOGIC PHARMACEUTICALS CORP net cash provided by (used in) continuing operations for fiscal 2013 was $50.62M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month | Net Cash Provided by (Used in) Continuing Operations 126 month |
|---|---|---|---|---|---|
| 2015-03-31 | $3.90M 10-Q · filed 2015-05-14 | -$49.49K derived: sum of 2 quarters · filed 2015-05-14 | -$23.27M derived: sum of 3 quarters · filed 2015-05-14 | -$3.75M derived: sum of 4 quarters · filed 2015-05-14 | |
| 2014-12-31 | -$3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$27.17M derived: sum of 2 quarters · filed 2015-02-26 | -$7.64M derived: sum of 3 quarters · filed 2015-02-26 | -$42.06M 10-K · filed 2015-02-26 | |
| 2014-09-30 | -$23.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$3.70M derived: sum of 2 quarters · filed 2014-11-05 | -$38.12M 10-Q · filed 2014-11-05 | $14.56M derived: sum of 4 quarters · filed 2015-05-14 | |
| 2014-06-30 | $19.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$14.89M 10-Q · filed 2014-08-05 | $37.78M derived: sum of 3 quarters · filed 2015-05-14 | $34.22M derived: sum of 4 quarters · filed 2015-05-14 | |
| 2014-03-31 | -$34.42M 10-Q · filed 2015-05-14 | $18.26M derived: sum of 2 quarters · filed 2015-05-14 | $14.70M derived: sum of 3 quarters · filed 2015-05-14 | $19.95M derived: sum of 4 quarters · filed 2015-05-14 | $20.72M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $52.68M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $49.12M derived: sum of 2 quarters · filed 2015-02-26 | $54.37M derived: sum of 3 quarters · filed 2015-02-26 | $50.62M 10-K · filed 2015-02-26 | |
| 2013-09-30 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $1.69M derived: sum of 2 quarters · filed 2014-11-05 | -$2.05M 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | $5.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $1.51M 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | -$3.75M 10-Q · filed 2014-05-08 |